Low — 0 expert voices in the KB; the call rests entirely on fundamentals and quant
Position sizing
Income/defensive sleeve only, ≤2% — a bond-proxy holding, not a growth allocation
Next catalyst
2026-07-30 Q2'26 earnings (Street EPS $1.04)
Single biggest risk
Regulatory/rate-case outcomes (esp. Illinois) — the allowed ROE is the earnings
One-line thesis. Ameren is a high-quality, low-beta Missouri/Illinois regulated electric-and-gas utility compounding earnings at a dependable ~6–8% off a growing rate base — but at 21× earnings and ~$121 street consensus the market already pays for that steadiness, so there is no discount to buy and the verdict is Watch.
◆ Synthos call — HoldAEE is a solid business largely reflected at ~$118 — fine to keep, no reason to chase; it gets interesting again below ~$100.
Downside Risk (lower = safer)
4/10 · Moderate
Low beta (0.49) & regulated cash flows, but ~4.9× net-debt/EBITDA, perennial negative FCF and 21× earnings for ~7% growth.
Growth Quality
5/10 · Moderate
Steady 6–8% EPS CAGR and ~12% ROE, but regulated cap keeps margins and returns range-bound — quality, not dynamism.
Exponential Potential
2/10 · Low
A rate-regulated monopoly with a fixed allowed return; data-center load is the only real upside optionality. Structurally non-exponential.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 11%/yrTo justify today’s $115, earnings would have to compound roughly 11% a year for 10 years (9% discount rate). Analysts forecast ~8%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Ameren is the power-and-gas company for 2.5 million electric and ~900,000 gas customers across Missouri and Illinois. It is a regulated monopoly: government regulators set the prices it can charge and the profit it's allowed to earn, so its earnings are steady and predictable — closer to a bond than a typical stock. It pays a 2.5% dividend.
Is the stock cheap or expensive? About fairly priced. You're paying roughly 21 dollars for every dollar of annual profit, which is a full price for a company that grows profits only about 7% a year. Wall Street's average price target ($121) is barely above today's $115, so there's little room to run. Our verdict is Watch — a fine, safe business, but not a bargain, so wait for a lower price.
Here's what our three scores mean in everyday terms:
Downside Risk 4/10 (fairly safe). The stock barely moves with the market and its revenue is guaranteed by regulation — but it carries a lot of debt and spends more than it earns on building power lines, so a stumble in rate cases or higher interest rates would hurt.
Growth Quality 5/10 (solid, average). Reliable, steady growth — but nothing dynamic. A regulator caps how much it can earn.
Exponential Potential 2/10 (low). A regulated monopoly can't suddenly explode in value; its profit is set by rules. The only wildcard is the surge of AI data centers needing power in its territory.
The one big worry: almost everything depends on regulators granting Ameren the rate increases and returns it asks for — especially in Illinois, where there's ongoing legal back-and-forth. If regulators say no, the earnings growth stalls.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLU (sector)), set to 100 a year ago
Solid = AEE · dashed = S&P 500 · dotted = XLU (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$115.02
Market cap$32B
P/E trailing5×
P/E FY26E / FY27E21× / 20×
EV / Sales3.7×
EV / EBITDA8.1×
Gross margin39.4%
Net margin17.2%
Dividend yield2.54%
Beta0.49
52-wk range$95 – $118
RSI(14)65
50 / 200-DMA$110 / $106
12-mo return+19% (SPY +21%)
Street target$121 ($115–$131)
Analyst grades11 Buy · 11 Hold · 1 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on AEE · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Ameren Corporation (NYSE: AEE) is a St. Louis-based utility holding company, founded 1881, that owns rate-regulated electric and natural-gas monopolies serving a 64,000-square-mile territory in Missouri and Illinois. It runs through four regulated segments: Ameren Missouri (generation + T&D), Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It generates power from coal, nuclear, and natural gas, plus hydro, wind, and solar. Fiscal year ends December 31.
Revenue mix (FY2025, from filings):
By product: Electricity $7.67B (87%) · Natural Gas $1.13B (13%). A predominantly electric utility.
By geography: FMP provides no geographic segmentation — the business is entirely U.S. (Missouri + Illinois), so this is a single-country, two-state regulated footprint.
The economic engine is simple and worth stating plainly: a regulated utility earns an allowed return on equity (ROE) on its rate base (the depreciated capital it has invested in poles, wires, plants, and pipes). Earnings grow by growing that rate base — i.e. by spending capital that regulators let it recover. Ameren's ~$4.2B/yr capex and multi-year rate plans are the whole growth story; the allowed ROE is the ceiling on how good it can get.
2. The expert thesis
There is no expert coverage of AEE in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0. No cautionary voice either. None of the tracked investor/analyst voices Synthos distills has made a traceable, dated claim on Ameren.
That is an honest and common outcome for a mid-cap regulated utility — these names rarely feature in the high-conviction podcast/letter ecosystem Synthos ingests, because they are bond-proxies, not thesis stocks. Accordingly, this verdict is entirely fundamentals- and quant-driven. We cite no claim_id values because there are none to cite; fabricating conviction here would violate the house standard. Read the scores and cases below as a pure numbers-and-structure read, not a distillation of expert opinion.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
4 · Low-Moderate
Beta 0.49 and regulated, recession-resilient cash flows are genuinely defensive — but ~4.9× net-debt/EBITDA, structurally negative free cash flow (capex > operating cash flow every year), and 21× earnings for ~7% growth leave little cushion if rates or rate-cases turn.
Growth Quality
5 · Average
Dependable 6–8% forward EPS CAGR, ~12% ROE, expanding rate base — solid and low-variance, but a regulator caps the allowed return, so margins and ROIC are range-bound by design. Quality without dynamism.
Exponential Potential
2 · Low
A rate-regulated monopoly cannot compound exponentially — its profit is a formula (allowed ROE × rate base). The only real optionality is a step-up in data-center/electrification load lifting the capex plan. Structurally non-exponential.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range.
Case
Key assumptions
Fair value
Bull
Data-center/electrification load accelerates the rate base; Missouri + Illinois rate cases land favorably; capex plan revised up. FY27E EPS beats to ~$6.05 and a scarcity bid lifts the multiple to ~22×.
~$133 (+16%)
Base(our anchor)
Guidance holds — FY26 EPS ~$5.35 (mid of the reaffirmed $5.25–$5.45 range), FY27E ~$5.81; a steady 6–8% regulated compounder earns its historical ~20.5×.
~$118 (+3%)
Bear
Adverse Illinois ICC/appellate outcomes, allowed-ROE compression, or higher-for-longer rates raise the cost of its heavy debt and dilutive equity issuance. FY27E EPS ~$5.45 on a de-rated ~16×.
~$87 (−24%)
Synthos fair value = the base case, ~$118 (+3%), with the full $87–$133 span as the honest range. This anchor sits just below the Street's $120.89 consensus — we see essentially no discount here. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). AEE is neither an exponential nor even a high-return compounder — it is a regulated rate-base grower, and that is a structurally different, lower-ceiling animal:
Acceleration (2nd derivative) is roughly flat-to-slightly-up: EPS growth runs ~7% (FY26E) → ~8% (FY27E) → ~8% (FY28–30E) on consensus. There is no inflection — this is the definition of a steady, non-accelerating profile. Per our flagship philosophy we pick forward next-exponentials; AEE is the opposite archetype.
Room to run — capped by design: a regulated monopoly earns an allowed ROE (~9–10%) on its rate base. It cannot "surprise to the upside" the way an unregulated growth business can, because excess returns get handed back to ratepayers at the next rate case. Its market cap vs. any "TAM" is the wrong lens — the ceiling is regulatory, not addressable-market.
The one genuine optionality: AI data-center load and electrification in its Missouri/Illinois footprint. If large new loads materialize, the capex plan (and therefore the rate base, and therefore EPS) steps up. This is the only path to a bull outcome, and it is why the score is 2 rather than 1.
Exponential Potential: Low (2/10). Own AEE for a dependable dividend and inflation-linked rate-base growth, never for a multibagger. This is a bond-with-a-pulse, not a growth engine.
Revenue: FY25 $8.80B, +15.4% (FY24 $7.62B; FY23 $7.50B). The FY25 jump partly reflects higher fuel/pass-through costs and rate increases, not organic volume — utility revenue is a noisy top line.
Quarterly trajectory: Q1'25 $2.10B → Q2 $2.22B → Q3 $2.70B → Q4 $1.78B → Q1'26 $2.18B. Seasonal (Q3 summer-cooling peak), as expected for an electric utility.
Margins: gross ~39% TTM, EBITDA margin ~46% TTM, net ~17%. Capital-intensive but stable.
Earnings: net income $1.456B FY25 (EPS $5.35 diluted), up from $1.182B (EPS $4.42) FY24 — a clean +21% EPS year, aided by rate relief. Q1'26 EPS $1.28 vs $1.07 (+20% YoY), beating the $1.18 estimate.
Returns on capital: ROE ~11.7% TTM, ROIC ~4.1%, ROA ~3.1% — respectable for a regulated utility, near its allowed ROE, and not going higher by design.
Cash flow — the key tell: operating CF $3.35B FY25, but capex −$4.17B, so free cash flow was −$821M — and FCF has been negative every year shown (−$1.6B FY24, −$1.2B FY23, −$1.1B FY22). This is normal for a utility in a heavy build cycle, but it means the dividend and growth are funded by continuous debt and equity issuance ($574M of new stock issued FY25; $1.1B net new debt). Dilution and leverage are baked into the model.
Balance sheet: total debt $19.83B, net debt $19.82B against ~$4.04B EBITDA → ~4.9× net-debt/EBITDA (typical for a regulated utility; note FMP's netDebtToEBITDA TTM field of 0.27× is distorted and should be ignored). Current ratio 0.62 — utilities run thin liquidity by design. Investment-grade, but interest expense ($776M FY25) is a real and rising headwind.
6. Valuation — priced in or room?
AEE trades at 21× trailing EPS, ~20× FY27E, 16× FY30E, EV/EBITDA 8.2×, P/B 2.3×, with a 2.5% dividend yield. For a business growing EPS ~7%, a low-20s P/E is a full multiple — the PEG is unfavorable (a ~21 P/E on ~7% growth ≈ 3×). The justification investors accept is the bond-proxy premium: guaranteed, recession-resistant cash flows and a growing dividend earn a higher multiple than the growth rate alone implies, especially when rates fall. The FMP letter rating (B+, DCF score 1/5, P/E score 2/5) flags the same thing — quality balance sheet, but not cheap.
Our base-case ~$118 (20.5× FY27E $5.81) lands essentially at today's price and just under the $120.89 street consensus (high $131, low $115 — note even the street low is at today's price, i.e. analysts see minimal downside but also minimal upside). There is no valuation discount to exploit here. Not a value buy; a fairly-priced quality utility — hence Watch, not Buy.
7. Technicals (from the tech block)
Trend:mild uptrend. $115.02 sits above the 50-DMA ($110.24) and 200-DMA ($106.35), 50 above 200 (constructive posture). MACD +1.42 (positive).
Location:−2.8% off the 52-week high ($118.32), +21% off the 52-week low ($95) — near the top of its range, shallow max drawdown (−2.8% from peak).
Momentum: RSI(14) 65 — firm but not yet overbought (<70).
Relative strength: AEE +19.3% 12-mo vs SPY +20.6% and QQQ +30.3% — a slight laggard to the market over 12 months (expected for a defensive utility in an up-tape); +14.2% 6-mo modestly ahead of SPY +8.4%, reflecting a recent rotation-to-safety bid.
Read: technicals are benign-to-mildly-positive — an orderly uptrend near highs, no distress and no euphoria. They neither argue for chasing nor warn of a break. Consistent with a fairly-valued defensive: nothing to act on.
8. Moat & competitive position
Ameren's moat is the strongest kind in theory and the most capped in practice: a legal, regulated monopoly. No competitor can string parallel wires to its 2.5M electric customers; barriers to entry are effectively absolute within its service territory. But that same regulation caps the upside — the allowed ROE means the monopoly rent flows largely to ratepayers, not shareholders. The "competition" that matters is not another utility; it is the regulator (Missouri PSC, Illinois ICC, FERC) and the political/affordability pressure on rates. The active Illinois ICC and appellate-court disputes flagged in the 8-K (§9) are the real competitive battleground.
Peer set (regulated electric/gas utilities, market cap): DTE Energy $32.0B (closest comp), Atmos Energy $29.5B, Fortis $29.5B, FirstEnergy $28.1B, Eversource $28.0B, PPL $27.8B, CMS Energy $24.0B, and the much larger Southern Company $110.5B. AEE sits mid-pack on size and trades broadly in line with the group's mid-to-high-teens forward multiple — no standout cheapness or premium versus peers.
9. Management, capital allocation & guidance
Capital allocation: the entire model is capex → rate base → earnings. ~$4.2B/yr into regulated infrastructure, funded by debt and equity issuance (FCF is structurally negative). Dividend is the shareholder return (2.5% yield, ~52% payout of EPS); no buybacks — appropriate, since the company issues stock to fund growth. This is textbook utility capital allocation.
Insider activity: the sampled window (early–mid 2026) shows routine executive sales (Moehn, Shaw, Martin — small 10b5-1-style dispositions) and an in-kind tax withholding by CEO Lyons, plus director awards. Nothing unusual — normal for a utility; no alarming discretionary cluster.
Management's own guidance (half-weighted — their own self-interested words): from the SEC 8-K / Q1'26 earnings release (May 5, 2026), management reaffirmed 2026 diluted EPS guidance of $5.25–$5.45 (assumes normal weather for the last nine months). CEO Martin J. Lyons framed the story as "disciplined ongoing infrastructure investment" to meet growing demand. The release is a genuine earnings release (Q1 EPS $1.28 vs $1.07, segment detail, guidance reaffirmation) — treat the $5.25–$5.45 range as a real, if self-interested, data point. It brackets our base-case FY26 assumption (~$5.35). Longer-dated (2027+) EPS/CAGR targets in this release were not captured beyond the consensus estimates in §5.
10. Catalysts & what to watch
Next earnings: 2026-07-30 (Q2'26; Street EPS $1.04, revenue ~$2.27B). Watch reaffirmation/revision of the $5.25–$5.45 FY26 range and any commentary on data-center load.
Illinois regulatory outcomes: the ICC multi-year rate plan (MYRP) orders and Ameren Illinois' pending appeals to the Illinois Appellate Court (electric distribution and natural gas) — the single biggest swing factor for the bear/base line. Adverse outcomes compress allowed returns.
Missouri rate cases & PISA: Ameren Missouri's plant-in-service accounting mechanism and any customer rate caps.
Data-center / electrification load: new large-load interconnections in the footprint would justify a step-up in the capex/rate-base plan — the bull trigger.
Interest-rate path: as a leveraged, negative-FCF, bond-proxy name, AEE's multiple and interest expense are both rate-sensitive.
Thesis tripwires (what would change the call): an unfavorable Illinois appellate ruling that compresses allowed ROE; the FY26 guidance range cut; or the multiple re-rating below ~16× (which would flip Watch toward a value entry).
11. Key risks
Regulatory (structural, the dominant risk): allowed-ROE and rate-case outcomes are the earnings. The Illinois ICC/appellate disputes flagged in the 8-K are live and material.
Leverage + negative FCF: ~4.9× net-debt/EBITDA and capex permanently above operating cash flow mean continuous debt and equity issuance — dilution and refinancing risk if rates stay high.
Interest-rate sensitivity: a bond-proxy with heavy debt; rising long rates pressure both the multiple and interest cost.
Valuation / no margin of safety: 21× for ~7% growth; even the street low target ($115) equals today's price.
Weather/commodity noise: earnings swing with temperatures (Q1'26 was hurt by a warm winter) and fuel-cost recovery timing.
Capital-plan dependency: the growth story requires regulators to keep approving a large capex program at recoverable returns.
12. Verdict, position sizing & monitoring
Watch. Ameren is a genuinely well-run, low-beta, dividend-paying regulated utility compounding EPS at a dependable ~6–8% off a growing rate base — a legitimate holding for an income/defensive sleeve. But at 21× earnings, ~$115 with a $120.89 street consensus and a base-case fair value of ~$118, there is essentially no margin of safety, and the business is structurally incapable of the acceleration Synthos hunts for (Exponential Potential 2/10). There is no expert conviction in the KB to lean on either. The honest call is to wait for a better price.
Sizing: if held at all, income/defensive only, ≤2% — a bond-proxy, not a growth position. A pullback toward the low-$100s / sub-16× would be a more attractive entry.
Monitoring: re-underwrite on Illinois regulatory rulings and each guidance update; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $115.02.
Single biggest risk: adverse regulatory/rate-case outcomes — the allowed ROE is the earnings.
Provenance & disclosures
Traceability: 0 KB claims, breadth 0 — no expert coverage of AEE in the Synthos KB. This note is explicitly fundamentals- and quant-driven; no claim_ids are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03. Forward figures are analyst consensus (FMP), labeled as estimates. Note: FMP's netDebtToEBITDA TTM field (0.27×) is distorted; the honest ~4.9× is used throughout.
Management caveat: the $5.25–$5.45 FY26 guidance is management's own, self-interested words (SEC 8-K, 2026-05-05), half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").